Safety of nonblood plasma substitutes: Less frequently discussed issues

European Journal of Anaesthesiology

Volumn 27, Issue 6, 2010, Pages 495-500

  Boldt, Joachim ^a  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

Author keywords

Dextrans; Gelatins; Human albumin; Hydroyxethyl starch; Plasma substitutes; Safety

Indexed keywords

GLUCOSE; HETASTARCH; PLASMA SUBSTITUTE; POTASSIUM;

ANTICOAGULATION; BLOOD CLOTTING; BLOOD GROUP TYPING; GLUCOSE BLOOD LEVEL; HUMAN; HYPOVOLEMIA; KIDNEY FUNCTION; NONHUMAN; PREGNANCY; PRURITUS; REVIEW;

EID: 77953805144     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0b013e328337d7d1     Document Type: Review

References (48)

1. British Guidelines on Intravenous Fluid Therapy for Adult Surgical Patients. http://www.asbi.org.uk/en/surgical-resources-and-documents/.
2. Boldt J, Schöllhorn T, Mayer J, et al. The value of an albumin-based intravascular volume replacement strategy in elderly patients undergoing major abdominal surgery. Anaesth Analg 2006; 103:191-199.
3. Finfer S, Bellomo R, Boyce N, et al., SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004; 350:2247-2256. (Pubitemid 38669207)
4. Alam HB, Rhee P. New developments in fluid resuscitation. Surg Clin North Am 2007; 87:55-72.
5. Jin SL, Yu BW. Effects of artificial colloids on haemostasis. Br J Hosp Med 2009; 70:101-103.
6. Westphal M, James MF, Kozek-Langenecker S, et al. Hydroxyethyl starches: different products - different effects. Anesthesiology 2009; 111:187-202.
7. Suttner S. Plasma substituites. In: Boldt J, editor. Volume replacement. Bremen: Uni-Med Verlag; 2004. pp. 28-57.
8. Winkelmayer WC, Glynn RJ, Levin R. Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgery. Kidney Int 2003; 64:1046-1049.
9. Haynes GH, Havidich JE, Payne KJ. Why the Food and Drug Administration changed the warning label for hetastarch. Anesthesiology 2004; 101:560-561.
10. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358:125-139.
11. Cada DJ, Levien T, Baker DE. Hydroxyethyl starch 130/0.4. Hosp Pharm 2008; 43:396-408.
12. Burns SM, Cowan CM, Wilkes RG. Prevention and management of hypotension during spinal anaesthesia for elective caesarean section: A survey of practice. Anaesthesia 2001; 56:794-798.
13. Ueyama H, He YL, Tanigami H, et al. Effects of crystalloid and colloid preload on blood volume in the parturient undergoing spinal anaesthesia for elective cesarean section. Anesthesiology 1999; 91:1571-1576.
14. Dahlgren G, Granath F, Pregner K, et al. Colloid vs. crystalloid preloading to prevent maternal hypotension during spinal anaesthesia for elective cesarean section. Acta Anaesthesiol Scand 2005; 49:1200-1206.
15. Murty SS, Kammath S, Chaudhari LS. Effects of hydroxyethyl starches on blood sugar levels: A randomized double blind study. Indian J Anaesth 2004; 48:196-200.
16. Hofer RE, Lanier WL. Effect of hydroxyethyl starch solutions on blood glucose concentrations in diabetic and nondiabetic rats. Crit Care Med 1992; 20:211-215.
17. Metze D, Reimann S, Szepfalusi Z, et al. Persistent pruritus after hydroxyethyl starch infusion therapy: A result of long-term storage in cutaneous nerves. Br J Dermatol 1997; 136:553-559.
18. Spittal MJ, Findlay GP. The seven year itch. Anaesthesia 1995; 50:913-914.
19. Gröchenig E, Albegger K, Dieterich HJ. Hydroxyethylstarch-related pruritus: A prospective multicentre investigation in 544 patients. Perfusion 1998; 11:62-69.
20. Bothner U, Georgieff M, Vogt NH. Assessment of the safety and tolerance of 6% hydroxyethyl starch (200/0.5) solution: A randomized, controlled epidemiology study. Anesth Analg 1998; 86:50-56.
21. Waitzinger J, Bepperling F, Pabst G, Opitz J. Hydroxyethyl starch (HES) [130/0.4], a new HES specification: Pharmacokinetics and safety after multiple infusions of 10% solution in healthy volunteers. Drugs R D 2003; 4:49-57.
22. Woessner R, Grauer MT, Dieterich HJ, et al. Influence of a long-term, high-dose volume therapy with 6% hydroxyethyl starch 130/0.4 or crystalloid solution on hemodynamics, rheology and haemostasis in patients with acute ischemic stroke. Results of a randomized, placebocontrolled, double-blind study. Pathophysiol Haemost Thromb 2003; 33:121-126.
23. Rudolf J, HES in Acute Stroke Study Group. Hydroxyethyl starch for hypervolemic hemodilution in patients with acute ischemic stroke: A randomized, placebo-controlled phase II safety study. Cerebrovasc Dis 2002; 14:33-41.
24. Klemm E, Bepperling F, Burschka MA, Mösges R. Haemodilution therapy with hydroxyethyl starch solution (130/0.4) in unilateral idiopathic sudden sensorineural hearing loss: A dose-finding, double-blind, placebocontrolled, international multicenter trial with 210 patients. Otol Neurotol 2007; 28:157-170.
25. Kasper SM, Strömich A, Kampe S, Radbruch L. Evaluation of a new hydroxyethyl starch solution (HES 130/0.4) in patients undergoing preoperative autologous blood donation. J Clin Anesth 2001; 13:486-490.
26. Levi M, Jonge E. Clinical relevance of the effects of plasma expanders on coagulation. Semin Thromb Haemost 2007; 33:810-815.
27. Kato A, Yonemura K, Matsushima H, et al. Complication of oliguric acute renal failure in patients treated with low-molecular weight dextran. Ren Fail 2001; 23:679-684.
28. Knutson JE, Deering JA, Hall FW, et al. Does intraoperative hetastarch administration increase blood loss and transfusion requirements after cardiac surgery. Anesth Analg 2000; 90:801-807.
29. Kozek-Langenecker SA. Effects of hydroxyethyl starch solutions on hemostasis. Anesthesiology 2005; 103:654-660.
30. Strauss RG, Pennell BJ, Stump DC. A randomized, blinded trial comparing the haemostatic effects of pentastarch versus hetastarch. Transfusion 2002; 42:27-36.
31. Kozek-Langenecker SA, Jungheinrich C, Sauermann W, van der Linden P. The effects of hydroxyethyl starch 130/0.4 (6%) on blood loss and use of blood products in major surgery: A pooled analysis of randomized clinical trials. Anesth Analg 2008; 107:382-690.
32. Blasco V, Leone M, Antonini F, et al. Comparison of the novel hydroxyethylstarch 130/0.4 and hydroxyethylstarch 200/0.6 in brain-dead donor resuscitation on renal function after transplantation. Br J Anaesth 2008; 100:504-508.
33. Boldt J, Ducke M, Kumle B, et al. Influence of different volume replacement strategies on inflammation and endothelial activation in the elderly undergoing major abdominal surgery. Intensive Care Med 2004; 30:416-422.
34. Neff TA, Doelberg M, Jungheinrich C, et al. Repetitive large-dose infusion of the novel hydroxyethyl starch 130/0.4 in patients with severe head injury. Anesth Analg 2003; 96:1453-1459.
35. Martini WZ. Coagulopathy by hypothermia and acidosis: Mechanisms of thrombingenerationandfibrinogenavailability.JTrauma2009;67:202-208.
36. Dickson DN, Gregory MA. Compatibility of blood with solutions containing calcium. Anesthesiology 1988; 68:115-121.
37. Ryden SE, Oberman HA. Compatibility of common intravenous solutions with CPD blood. Surg Gynecol Obstet 1991; 173:9-12.
38. Albert K, van Vlymen J, James P, Parlow J. Ringer's lactate is compatible with the rapid infusion of AS-3 preserved packed red blood cells. Can J Anaesth 2009; 56:352-356.
39. Nadra A, Hodzovic I. Incompatability between blood and Hartmann's solution. Anaesthesia 2007; 62:639.
40. Kox W, Höwekamp C. Effect of various plasma substitutes on blood groups. Infusionsther Klin Ernahr 1979; 6:341-344.
41. Kleine N. The influence of the plasmaexpander hydroxyethyl starch on the serological blood grouping tests as compared to dextran 60 and whole blood. Anaesthesist 1975; 24:225-227.
42. Bartholomew JR, Bell WR, Kickler T, Williams GM. A prospective study of the effect of dextran administration on compatibility testing. Transfusion 1986; 26:431-433.
43. Doenicke A,Grote B, Lorenz W. Blood and blood substitutes. Br J Anaesth 1977; 49:681-688.
44. Janes AW, Mishler JM, Lowes B. Serial infusion effects of hydroxyethyl starch on ESR, blood typing and crossmatching and serum amylase levels. Vox Sang 1977; 32:131-134.
45. Daniels MJ, Strauss RG, Smith-Floss AM. Effects of hydroxyethyl starch on erythrocyte typing and blood crossmatching. Transfusion 1982; 22:226-228.
46. O'Malley CM, Frumento RJ, Hardy MA, et al. A randomized, double-blind comparison of lactated Ringer's solution and 0.9% NaCl during renal transplantation. Anesth Analg 2005; 100:1518-1524.
47. O'Malley CM, Frumento RJ, Bennett-Guerrero E. Intravenous fluid therapy in renal transplant recipients: Results of a US survey. Transplant Proc 2002; 34:3142-3145.
48. Prough DS. Acidosis associated with perioperative saline administration. Anesthesiology 2000; 93:1184-1887.